Related references
Note: Only part of the references are listed.The spread of CTX-M-type extended-spectrum beta-lactamases
G. M. Rossolini et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups
Angela Novais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris Area, Tunis, and Bangui
M. Lavollay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 β-lactamases at 2 hospitals in Taiwan
LT Wu et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Occurrence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases among Korean isolates of Proteus mirabilis
YJ Park et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
DNA sequence analysis of the genetic environment of various bla(CTX-M) genes
C Eckert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
CTX-M-1 extended-spectrum β-lactamase-producing Proteus mirabilis in Greece
P Karapavlidou et al.
MICROBIAL DRUG RESISTANCE (2005)
Identification of plasmids by PCR-based replicon typing
A Carattoli et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters
BV Jones et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Occurrence and molecular analysis of extended-spectrum β-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002
PL Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital
M Biendo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003
M Batchelor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of the restriction enzyme EcoRI for pulsed-field gel electrophoretic analysis of Helicobacter pylori
Y Hosaka et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
CTX-M: changing the face of ESBLs in the UK
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
CFE-1, a novel plasmid-encoded AmpC β-lactamase with an ampR gene originating from Citrobacter freundii
R Nakano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals
MV Villegas et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Nosocomial outbreak by Proteus mirabilis producing extended-spectrum β-lactamase VEB-1 in a Korean university hospital
JY Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Evolutionary mapping of the SHV β-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome
PJ Ford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Extended-spectrum β-lactamases in Enterobactetiaceae in Buenos Aires, Argentina, public hospitals
M Quinteros et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase
N Nagano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
FJ Pérez-Pérez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Early dissemination of CTX-M-derived enzymes in South America
M Radice et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland
A Baraniak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
PA Bradford
CLINICAL MICROBIOLOGY REVIEWS (2001)
Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem
H Yano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of β-lactam/β-lactamase inhibitor combinations
F Luzzaro et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis:: a 2-year survey in a French hospital
C Chanal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns
G Saurina et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Clinical relevance of Proteus mirabilis in hospital patients:: a two year survey
C de Champs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
